| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |